$2.55
0.041.59%
At Close: -
$2.48
-0.07-2.75%
After Hours: Jul 25, 8:37 AM EDT
15 minutes delayed
Comments
Loading...
Turnstone Biologics (NASDAQ:TSBX) Stock, Analyst Ratings, Price Targets, Forecasts
Turnstone Biologics Corp has a consensus price target of $19 based on the ratings of 2 analysts. The high is $20 issued by Piper Sandler on August 15, 2023. The low is $18 issued by B of A Securities on August 15, 2023. The 2 most-recent analyst ratings were released by B of A Securities and Piper Sandler on August 15, 2023, respectively. With an average price target of $19 between B of A Securities and Piper Sandler, there's an implied 666.13% upside for Turnstone Biologics Corp from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
B of A Securities
Piper Sandler
1calculated from analyst ratings
Analyst Ratings for Turnstone Biologics
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 08/15/2023 | Buy Now | 625.81% | B of A Securities | Geoff Meacham | → $18 | Initiates | → Buy | Get Alert |
| 08/15/2023 | Buy Now | 706.45% | Piper Sandler | Joseph Catanzaro | → $20 | Initiates | → Overweight | Get Alert |
FAQ
What is the target price for Turnstone Biologics (TSBX) stock?
The latest price target for Turnstone Biologics (NASDAQ:TSBX) was reported by B of A Securities on August 15, 2023. The analyst firm set a price target for $18.00 expecting TSBX to rise to within 12 months (a possible 625.81% upside). 2 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Turnstone Biologics (TSBX)?
The latest analyst rating for Turnstone Biologics (NASDAQ:TSBX) was provided by B of A Securities, and Turnstone Biologics initiated their buy rating.
When was the last upgrade for Turnstone Biologics (TSBX)?
There is no last upgrade for Turnstone Biologics
When was the last downgrade for Turnstone Biologics (TSBX)?
There is no last downgrade for Turnstone Biologics.
When is the next analyst rating going to be posted or updated for Turnstone Biologics (TSBX)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Turnstone Biologics, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Turnstone Biologics was filed on August 15, 2023 so you should expect the next rating to be made available sometime around August 15, 2024.
Is the Analyst Rating Turnstone Biologics (TSBX) correct?
While ratings are subjective and will change, the latest Turnstone Biologics (TSBX) rating was a initiated with a price target of $0.00 to $18.00. The current price Turnstone Biologics (TSBX) is trading at is $2.48, which is within the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.